A biphasic relation between insulin resistance and change in BMD is plausible; experimental data show that insulin has anabolic or catabolic actions on bone under different conditions and that bone itself can be an end-organ site of insulin resistance (2–7). The gene discussed is INS; the disease is Insulin resistance.